PLDT Inc. Sponsored ADR (PHI)

Cost of Revenue

₱78.38B

TTM · Period ending: · PHP

PHI logo

PHI Cost of Revenue

Latest reported₱78.38B PHP
PHI TTM Cost of Revenue · PHP (₱0.00 → ₱78.38B)
High-resolution chart · PNG

PHI cost of revenue history

Trailing twelve months (TTM) · PHP. Each value covers four complete reported quarters.

PLDT Inc. Sponsored ADR Cost of Revenue — Trailing twelve months (TTM) (PHP)
Period endingCost of Revenue (PHP)
78,384,235,102
62,875,865,000
62,147,226,000
53,039,000,000
53,070,000,000
52,402,000,000
50,877,000,000
50,608,000,000
49,833,000,000
48,930,000,000
40,833,000,000
38,966,000,000
38,374,000,000
37,168,000,000
34,970,000,000
33,195,000,000
31,523,000,000
30,988,000,000
29,898,000,000
28,536,000,000
28,925,000,000
27,848,000,000
25,618,000,000
26,056,000,000
26,177,000,000
27,535,000,000
27,818,000,000
26,021,000,000
26,821,000,000
35,072,000,000
35,779,000,000
35,875,000,000
35,661,000,000
28,428,000,000
27,597,000,000
23,001,000,000
32,853,000,000
44,306,000,000
52,411,000,000
64,607,000,000
65,317,000,000
65,271,000,000
63,643,000,000
60,026,000,000
59,649,000,000
57,898,000,000
57,639,000,000
59,055,000,000
58,025,000,000
57,308,000,000
55,891,000,000
52,528,000,000
51,670,000,000
41,960,000,000
34,179,000,000
47,963,000,000
36,056,000,000
32,702,000,000
28,420,000,000
14,227,000,000
14,222,000,000
14,264,000,000
14,205,000,000
5,122,000,000
5,258,000,000
5,419,000,000
5,431,000,000
5,501,605,000
5,517,169,000
5,656,169,000
5,428,169,000
4,898,763,000
4,697,947,000
4,606,499,000
4,851,350,000
6,052,773,000
6,331,426,000
6,232,107,000
6,311,767,000
6,030,639,000
6,142,013,000
6,102,295,000
6,851,181,000
7,469,137,000
8,765,351,000
10,333,979,000
10,329,054,000
23,577,372,000
21,279,372,000
21,797,256,000
23,373,768,000
18,332,626,530
19,495,495,530
17,948,579,530
16,250,044,530
3,236,683,000
5,030,331,000
6,666,210,000
8,116,107,501
16,539,604,638
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.